pyrazole has been researched along with Multiple Myeloma in 1 studies
1H-pyrazole : The 1H-tautomer of pyrazole.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jorda, R | 1 |
| Navrátilová, J | 1 |
| Hušková, Z | 1 |
| Schütznerová, E | 1 |
| Cankař, P | 1 |
| Strnad, M | 1 |
| Kryštof, V | 1 |
1 other study available for pyrazole and Multiple Myeloma
| Article | Year |
|---|---|
Arylazopyrazole AAP1742 inhibits CDKs and induces apoptosis in multiple myeloma cells via Mcl-1 downregulation.
Topics: Antineoplastic Agents; Apoptosis; Azo Compounds; Cell Line, Tumor; Cyclin-Dependent Kinase 9; Down-R | 2014 |